Off-Label Testosterone Therapy Linked to Long-Term Cardiovascular Risk: Study

Germany: A retrospective real-world cohort study has found that off-label testosterone therapy in men without evidence of hypogonadism was associated with an increased risk of cardiovascular events...
Read the full report on Business Medical Dialogues
Story file
- Section
- Health
- Topics
- Health alerts
- First reported by
- Business Medical Dialogues
- Reporter
- medha baranwal
- Published
- Saturday, 10 October 2026, 6:15 am IST
- Coverage
- One outlet so far
How this page works. The Headline Update lists this report from Business Medical Dialogues with a short summary and a link to the original. The original reporting and photograph belong to the publisher. Spotted an error in our summary? Tell our corrections desk.


